Implications of SCFAs on the Parameters of the Lipid and Hepatic Profile in Pregnant Women

Overview

Journal Nutrients

Date 2021 Jun 2

PMID 34063900

Citations 19

Authors

Maciej Zietek

Zbigniew Celewicz

Justyna Kikut

Malgorzata Szczuko

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of the study was to analyze the correlation of SCFAs with lipid and hepatic metabolism during pregnancy in relation to the body weight of pregnant women.

Material And Methods: This study was conducted in pregnant women divided into two groups: Obese (OW-overweight and obese women; = 48) and lean (CG-control group; = 48) individuals. The biochemical plasma parameters of lipid metabolism (TG, CH, LDL, HDL), inflammation (CRP), and liver function (ALT, AST, GGT) were determined in all of the subjects. SCFA analysis was performed in the stool samples to measure acetic acid (C 2:0), propionic acid (C 3:0), isobutyric acid (C 4:0 i), butyric acid (C 4:0 n), isovaleric acid (C 5:0 i) valeric acid (C 5:0 n), isocaproic acid (C 6:0 i), caproic acid (C 6:0 n), and heptanoic acid (C 7:0).

Results: Statistically significant differences in the concentrations of C 3:0 and C 6:0 n were found between women in the OW group compared to the CG group. The other SCFAs tested did not differ significantly depending on BMI. The C 2:0, C 3:0, and C 4:0 n ratios showed differences in both OW and CG groups. In the OW group, no relationship was observed between the concentrations of the SCFAs tested and CRP, ALT, AST. A surprising positive relationship between C 5:0 n and all fractions of the tested lipids and branched C 5:0 with CHL, HDL, and LDL was demonstrated. In the OW group, HDL showed a positive correlation with C 3:0. However, lower GGT concentrations were accompanied by higher C 4:0 and C 5:0 values, and this tendency was statistically significant.

Conclusions: The results of our research show that some SCFAs are associated with hepatic lipid metabolism and CRP concentrations, which may vary with gestational weight. Obesity in pregnancy reduces the amount of SCFAs in the stool, and a decrease in the level of butyrate reduces liver function.

Citing Articles

The Association of Short-Chain Fatty Acids with the Occurrence of Gastrointestinal Symptoms in Infants.

Szczuko M, Duliban G, Drozd A, Sochaczewska D, Pokorska-Niewiada K, Zietek M Int J Mol Sci. 2024; 25(23).

PMID: 39684199 PMC: 11641760. DOI: 10.3390/ijms252312487.

The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver-A Secondary Analysis of the Pro-Demet Randomized Clinical Trial.

Gawlik-Kotelnicka O, Rogalski J, Czarnecka-Chrebelska K, Burzynski J, Jakubowska P, Skowronska A Nutrients. 2024; 16(23).

PMID: 39683419 PMC: 11643736. DOI: 10.3390/nu16234024.

Interactions between host and gut microbiota in gestational diabetes mellitus and their impacts on offspring.

Wang S, Cui Z, Yang H BMC Microbiol. 2024; 24(1):161.

PMID: 38730357 PMC: 11083820. DOI: 10.1186/s12866-024-03255-y.

Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome.

Charitos I, Aliani M, Tondo P, Venneri M, Castellana G, Scioscia G Int J Mol Sci. 2024; 25(5).

PMID: 38474087 PMC: 10931779. DOI: 10.3390/ijms25052841.

Revisiting multi-omics-based predictors of the plasma triglyceride response to an omega-3 fatty acid supplementation.

Morin-Bernier J, de Toro-Martin J, Barbe V, San-Cristobal R, Lemieux S, Rudkowska I Front Nutr. 2024; 11:1327863.

PMID: 38414488 PMC: 10897027. DOI: 10.3389/fnut.2024.1327863.

References

Myatt L, Maloyan A . Obesity and Placental Function. Semin Reprod Med. 2016; 34(1):42-9. DOI: 10.1055/s-0035-1570027. View

Feng G, Feng L, Zhao Y . Association between ratio of γ-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. Ann Transl Med. 2020; 8(10):634. PMC: 7290624. DOI: 10.21037/atm-19-4516. View

Vojinovic D, Radjabzadeh D, Kurilshikov A, Amin N, Wijmenga C, Franke L . Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat Commun. 2019; 10(1):5813. PMC: 6925111. DOI: 10.1038/s41467-019-13721-1. View

Gomez-Arango L, Barrett H, McIntyre H, Callaway L, Morrison M, Nitert M . Connections Between the Gut Microbiome and Metabolic Hormones in Early Pregnancy in Overweight and Obese Women. Diabetes. 2016; 65(8):2214-23. DOI: 10.2337/db16-0278. View

Liu B, Qian J, Wang Q, Wang F, Ma Z, Qiao Y . Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion. PLoS One. 2014; 9(8):e106184. PMC: 4149529. DOI: 10.1371/journal.pone.0106184. View

Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilan C, Salazar N . Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol. 2016; 7:185. PMC: 4756104. DOI: 10.3389/fmicb.2016.00185. View

Aguirre M, Eck A, Koenen M, Savelkoul P, Budding A, Venema K . Diet drives quick changes in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model. Res Microbiol. 2015; 167(2):114-25. DOI: 10.1016/j.resmic.2015.09.006. View

Schoeler M, Caesar R . Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019; 20(4):461-472. PMC: 6938793. DOI: 10.1007/s11154-019-09512-0. View

Gohir W, Kennedy K, Wallace J, Saoi M, Bellissimo C, Britz-McKibbin P . High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers. J Physiol. 2019; 597(12):3029-3051. DOI: 10.1113/JP277353. View

10.

Granado-Serrano A, Martin-Gari M, Sanchez V, Riart Solans M, Berdun R, Ludwig I . Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia. Sci Rep. 2019; 9(1):1772. PMC: 6370822. DOI: 10.1038/s41598-019-38874-3. View

11.

Nakajima A, Kaga N, Nakanishi Y, Ohno H, Miyamoto J, Kimura I . Maternal High Fiber Diet during Pregnancy and Lactation Influences Regulatory T Cell Differentiation in Offspring in Mice. J Immunol. 2017; 199(10):3516-3524. DOI: 10.4049/jimmunol.1700248. View

12.

Soderborg T, Carpenter C, Janssen R, Weir T, Robertson C, Ir D . Gestational Diabetes Is Uniquely Associated With Altered Early Seeding of the Infant Gut Microbiota. Front Endocrinol (Lausanne). 2020; 11:603021. PMC: 7729132. DOI: 10.3389/fendo.2020.603021. View

13.

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

14.

Kobyliak N, Virchenko O, Falalyeyeva T . Pathophysiological role of host microbiota in the development of obesity. Nutr J. 2016; 15:43. PMC: 4841968. DOI: 10.1186/s12937-016-0166-9. View

15.

Conlon M, Bird A . The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014; 7(1):17-44. PMC: 4303825. DOI: 10.3390/nu7010017. View

16.

Hara H, Haga S, Aoyama Y, Kiriyama S . Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999; 129(5):942-8. DOI: 10.1093/jn/129.5.942. View

17.

Al-Daihan S, Bhat R . Impact of Propionic Acid on Liver Damage in Rats. Int J Mol Cell Med. 2015; 4(3):188-95. PMC: 4644531. View

18.

Priyadarshini M, Thomas A, Reisetter A, Scholtens D, Wolever T, Josefson J . Maternal short-chain fatty acids are associated with metabolic parameters in mothers and newborns. Transl Res. 2014; 164(2):153-7. PMC: 4156825. DOI: 10.1016/j.trsl.2014.01.012. View

19.

Yamashita H, Fujisawa K, Ito E, Idei S, Kawaguchi N, Kimoto M . Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem. 2007; 71(5):1236-43. DOI: 10.1271/bbb.60668. View

20.

Nuriel-Ohayon M, Neuman H, Koren O . Microbial Changes during Pregnancy, Birth, and Infancy. Front Microbiol. 2016; 7:1031. PMC: 4943946. DOI: 10.3389/fmicb.2016.01031. View